Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2Genitourinary 2Sarcoma 1Lymphoid 1Gynecologic 1Gastrointestinal 1Endocrine 1CNS 1Breast 1

Conditions

Glioblastoma 8Brain Neoplasms 8Breast Neoplasms 4Urinary Bladder Neoplasms 3Thyroid Neoplasms 3Ovarian Neoplasms 3Neuroendocrine Tumors 3Neoplasm Metastasis 3Glioma 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Testicular Neoplasms 2Stomach Neoplasms 2Spinal Cord Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Pheochromocytoma 2Paraganglioma 2Pancreatic Neoplasms 2Neoplasms 2Meningioma 2Lung Neoplasms 2Gliosarcoma 2Carcinoma, Transitional Cell 2Astrocytoma 2Adrenal Gland Neoplasms 2Vaginal Neoplasms 1

Interventions

pembrolizumab 1Quality of Life 1Patient Reported Outcome Measures 1PM 01183 1Nivolumab 1Molecular Diagnostic Techniques 1LY2940680 1Irinotecan 1Immunotherapy, Adoptive 1Immunotherapy 1Fluorodeoxyglucose F18 1Drug Therapy 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mesothelioma × Fluorodeoxyglucose F18 × CNS × Clear all
NCT06503146 2026-05-19

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
320 enrolled
CNSEndocrineGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Carcinoma, Hepatocellular, Mesothelioma, Ovarian Neoplasms, Paraganglioma, Pheochromocytoma, Sarcoma, Stomach Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡